|
Jun 14
|
Euronext Paris Growth Companies With High Insider Ownership And Up To 40% Revenue Growth
|
|
Jun 13
|
June 2024 Insight Into Euronext Paris Growth Stocks With High Insider Ownership
|
|
Jun 12
|
High Insider Ownership Growth Stocks On Euronext Paris In June 2024
|
|
Jun 12
|
Exploring Three Growth Companies With High Insider Ownership On Euronext Paris
|
|
Jun 11
|
Euronext Paris Growth Companies With High Insider Ownership And 40% Revenue Growth
|
|
Jun 11
|
Medincell Joins the Euronext Tech Leaders
|
|
Jun 11
|
Euronext Paris Growth Companies With High Insider Ownership And Up To 101% Earnings Growth
|
|
Apr 8
|
Unitaid Awards Medincell up to $6 million Extension Grant to Fight Malaria
|
|
Jan 11
|
Half-Year Liquidity Contract Statement For MEDINCELL
|
|
Jan 9
|
MedinCell’s partner Teva Announces Recruitment Completion of Phase 3 Clinical Study of mdc-TJK / Olanzapine Long-Acting Injectable (LAI)
|
|
Jan 4
|
Jefferies Initiates MedinCell’s Coverage with a "Buy" Recommendation
|
|
Dec 19
|
MedinCell Publishes Its Consolidated Half-year Financial Results
|
|
Nov 6
|
MedinCell at the 2023 Jefferies Global Healthcare Conference - London, 14-16 November
|